Publications en collaboration avec des chercheurs de Hospital Universitario 12 de Octubre (12)

2024

  1. Psoriasis induced by antiTNF therapy in inflammatory bowel disease: Therapeutic management and evolution of both diseases in a nationwide cohort study

    Digestive and Liver Disease

2023

  1. Analysis of the degree of implementation of medication error prevention practices in Spanish hospitals (2022)

    Farmacia Hospitalaria, Vol. 47, Núm. 6, pp. 268-276

  2. Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry

    Journal of Crohn's & colitis, Vol. 17, Núm. 1, pp. 83-91

  3. p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

    Journal of Pathology: Clinical Research, Vol. 9, Núm. 3, pp. 208-222

2022

  1. Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study

    Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736

  2. Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry

    Journal of Clinical Medicine, Vol. 11, Núm. 2

2019

  1. Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients

    Clinical and Translational Oncology, Vol. 21, Núm. 4, pp. 467-478

2007

  1. Sucesos adversos en cirugía general y de aparato digestivo en los hospitales españoles

    Cirugia Espanola, Vol. 82, Núm. 5, pp. 268-277

  2. Un aspecto crítico de la calidad: Los sucesos adversos en los hospitales españoles: Resultados del estudio eneas

    Medicina Preventiva, Vol. 13, Núm. SPEC. ISS., pp. 64-70

2001

  1. Covariate effects on the apparent clearance of tacrolimus in paediatric liver transplant patients undergoing conversion therapy

    Clinical Pharmacokinetics, Vol. 40, Núm. 1, pp. 63-71

1998

  1. Influence of diagnostic and treatment factors in the population pharmacokinetics of gentamicin

    Journal of Clinical Pharmacy and Therapeutics, Vol. 23, Núm. 2, pp. 141-148

1988

  1. Acute lymphoblastic leukemia type T: Therapeutic results

    Anales Espanoles de Pediatria, Vol. 29, Núm. SUPPL. 34, pp. 62-66